// App-Quantinova.ai

P047 : Analysis of 6-Month Confirmed Disability Progression in RRMS Patients Treated with Subcutaneous Interferon Beta-1a

Researchers

Presenter

  • Ms. Schiffon L Wong

Principal Investigators

  • Ms. Julie Aldrige

  • Mr. Robert Hettle

  • Mr. Inderpreet S Khurana

  • Mr. Mohd K Siddiqui

Medical Centers

  • EMD Serono, Inc, Billerica, MA

  • EMD Serono, Inc, Billerica, MA

  • 2PAREXEL International, London, UK London United Kingdom

  • PAREXEL International, Mohali, India

Locations

  • United States

  • United Kingdom

  • India

Companies

  • N/A

Study Components

Therapeutic Area

  • Dermatology

  • Genetic Disorder

Disease

  • Ectodermal dysplasia-syndactyly syndrome

Biomarkers

  • Interferon

Drug/Treatment

  • Interferon beta-1a

Outcome

  • N/A

Study Design

  • Randomized

  • Placebo Control

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved